Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Neoplasms 1Leiomyoma 1

Interventions

asoprisnil 6ulipristal acetate 3Hysterectomy 2relugolix 1cetrorelix 1Videotape Recording 1Uterine Artery Embolization 1Triptorelin Pamoate 1Tablets 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Salpingectomy 1Rocuronium 1Robotic Surgical Procedures 1Restraint, Physical 1Naproxen 1Mifepristone 1Menotropins 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1High-Energy Shock Waves 1Gonadotropins 1Electrocoagulation 1Chorionic Gonadotropin 1Bupivacaine 1Anesthesia, General 1Analgesia, Patient-Controlled 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyoma × Leuprolide × Gynecologic × Clear all
NCT00776074 2010-06-22

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Takeda

Phase 2 Completed
80 enrolled
Gynecologic

Leiomyoma, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡